Nu Skin recalls Pharmanex Cortitrol capsules due to undeclared soy allergen
Nu Skin recalls Pharmanex Cortitrol 60-capsule cortisol management product for undeclared soy allergen. Affected batches include DL06951-08, DL14251-08, DL34351-08, DL06061-08, DL27161-08.
Use caution until it’s fixed
Nu Skin announces a voluntary field action for Pharmanex Cortitrol due to undeclared allergen; soy.
Contact the company
What happened, in plain English
Nu Skin is recalling Pharmanex Cortitrol 60-capsule cortisol management products because they contain an undeclared soy allergen. This poses a risk for people with soy allergies who may react to the product. Read more at govinfonow.com/recall/22285-nu-skin-recalls-pharmanex-cortitrol-capsules-due-to-undeclared-soy.
Source Summary by GovInfoNow · govinfonow.com/recall/22285-nu-skin-recalls-pharmanex-cortitrol-capsules-due-to-undeclared-soy · Updated October 8, 2026 · FDA enforcement record: FDA #F-1579-2017
Cite this page
“Nu Skin recalls Pharmanex Cortitrol capsules due to undeclared soy allergen.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/22285-nu-skin-recalls-pharmanex-cortitrol-capsules-due-to-undeclared-soy. Based on FDA recall #F-1579-2017 (https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-1579-2017%22&limit=1).
Why it’s dangerous
The product contains soy as an ingredient but this allergen was not declared on the label. People with soy allergies could have an allergic reaction if they take the product.
Who’s affected
People who have soy allergies are at risk of allergic reactions from this product. Those who purchased the recalled batches should check their product labels.
How to tell if you have this one
Check for batch numbers DL06951-08, DL14251-08, DL34351-08, DL06061-08, or DL27161-08 on the product packaging. The product is labeled as 'Pharmanex Cortitrol. Cortisol Management. 60 Capsules'.
- Brand
Nu Skin- Category
Food
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide, Canadian and other foreign consignees. No VA/govt/military consignees.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| F-1578-2017 | Pharmanex BioGinkgo. Mental Sharpness. 60 Tablets; Batches: DL14951-07, DL31551-07, DL21161-07 | 40,158 |
| F-1579-2017 | Pharmanex Cortitrol. Cortisol Management. 60 Capsules; Batches: DL06951-08, DL14251-08, DL34351-08, DL06061-08, DL27161-08 | 56,332 |
| F-1580-2017 | Pharmanex Cholestin. Cholesterol Health. 60 Softgels.; Batch: CS10351 | 7,327 |
What to do — step by step
Check Product Label
Look for batch numbers DL06951-08, DL14251-08, DL34351-08, DL06061-08, or DL27161-08 on the product packaging.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Nationwide, Canadian and other foreign consignees. No VA/govt/military consignees.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 6 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product safe for people without soy allergies?
Yes, the product is safe for people without soy allergies as the hazard is specific to those with soy allergies.
Similar recalls
Latest food recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #F-1579-2017 (February 13, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for F-1579-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.